- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer ; volume:14 ; number:1 ; day:11 ; month:1 ; year:2024 ; pages:1-15 ; date:12.2024
Scientific reports ; 14, Heft 1 (11.1.2024), 1-15, 12.2024
- Creator
-
Liu, Xiong
Yuan, Renming
Peng, Jie
Xu, Ailei
Nie, Xiaoxia
Tang, Ruiti
Li, Guangqiang
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-51720-5
- URN
-
urn:nbn:de:101:1-2405152117072.686223901809
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Liu, Xiong
- Yuan, Renming
- Peng, Jie
- Xu, Ailei
- Nie, Xiaoxia
- Tang, Ruiti
- Li, Guangqiang
- SpringerLink (Online service)
Other Objects (12)
Pan-cancer analysis of COL15A1: an immunological and prognostic biomarker
MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker
PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer
Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
PHF5A is a potential diagnostic, prognostic, and immunological biomarker in pan-cancer
Systematic pan-cancer landscape identifies CARM1 as a potential prognostic and immunological biomarker
Author Correction: SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer
A pan-cancer analysis of thioredoxin-interacting protein as an immunological and prognostic biomarker
Comprehensive pan-cancer analysis of ZNF337 as a potential diagnostic, immunological, and prognostic biomarker
Systematic analysis identifies XRCC4 as a potential immunological and prognostic biomarker associated with pan-cancer
Pan-cancer analysis of COL15A1: an immunological and prognostic biomarker
MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker
PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer
Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
PHF5A is a potential diagnostic, prognostic, and immunological biomarker in pan-cancer
Systematic pan-cancer landscape identifies CARM1 as a potential prognostic and immunological biomarker
Author Correction: SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer
A pan-cancer analysis of thioredoxin-interacting protein as an immunological and prognostic biomarker
Comprehensive pan-cancer analysis of ZNF337 as a potential diagnostic, immunological, and prognostic biomarker
Systematic analysis identifies XRCC4 as a potential immunological and prognostic biomarker associated with pan-cancer
Pan-cancer analysis of COL15A1: an immunological and prognostic biomarker
MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker
PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer
Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
PHF5A is a potential diagnostic, prognostic, and immunological biomarker in pan-cancer
Systematic pan-cancer landscape identifies CARM1 as a potential prognostic and immunological biomarker
Author Correction: SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer
A pan-cancer analysis of thioredoxin-interacting protein as an immunological and prognostic biomarker
Comprehensive pan-cancer analysis of ZNF337 as a potential diagnostic, immunological, and prognostic biomarker